MEI Pharma makes history: first publicly traded biotech to convert its cash exclusively into $LTC .
Charlie Lee, founder of Litecoin, joins their board of directors to guide this strategic decision.
The results were immediate:
• +83 % for MEIP stock
• +12 % for the price of $LTC
In the wake, Luxxfolio also strengthens its positions by doubling its reserves.
Institutional adoption of Litecoin is accelerating.
